Tag: Cancer: Leukemia
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
Increased risk for death and relapse seen for children with overweight, obesity at two or more time points
Molecular Monitoring Improves Survival in Some Patients With Newly Diagnosed Leukemia
Sequential molecular measurable residual disease monitoring, coupled with guided treatment, beneficial for patients with NPM1 and FLT3 mutations
Statin Use Improves Outcomes in Chronic, Small Lymphocytic Leukemia
Improvements seen in overall survival, progression-free survival, and cancer-specific survival
Disparities Identified in Leukemia Incidence, Mortality in Florida
Odds of leukemia-related mortality higher in rural counties and urban neighborhoods with lower socioeconomic status
Acalabrutinib-Venetoclax Prolongs Survival in Previously Untreated Leukemia
Progression-free survival significantly lower with fixed-duration acalabrutinib-venetoclax with or without obinutuzumab
Position Statement Developed for Managing Blood Cancers in Pregnancy
Multidisciplinary collaborative approach to care is required for patients with hematological malignancies in pregnancy
Neurocognitive Battery Feasible in 3-Year-Olds During Leukemia Treatment
3-year-old patients did not differ from 4-year-olds in terms of ability to perform or complete testing
ASH: Blinatumomab + Chemo Aids Survival in B-Cell Acute Lymphoblastic Leukemia
Estimated disease-free survival 97.5 ± 1.3 and 90.2 ± 2.3 percent with chemotherapy plus blinatumomab, chemo alone in average-risk patients
Durable Response High With Obe-Cel in B-Cell Acute Lymphoblastic Leukemia
Overall remission occurred in 77 percent of patients in a cohort with morphologic disease
COVID-19 Mortality Higher for Leukemia, Myelodysplastic Syndrome Patients
However, risk for hospitalization no higher for COVID-19 in these patients
